One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-118828
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 4 |
Affiliation: Spinal Cord Injury BC, Memorial Sloan Kettering Cancer Center, Centre Antoine Lacassagne, Mayo Clinic, Samsung Medical Center, Cancer Prevention Institute of California, Washington University in St. Louis, Duran i Reynals Hospital, Institut Català d'Oncologia, Rigshospitalet, Jagiellonian University, Seagen (United States), Takeda (United States), Millennium Engineering and Integration (United States), Manchester Academic Health Science Centre, University of ManchesterBrentuximab Vedotin Plus Chemotherapy in Patients with Advanced-Stage Classical Hodgkin Lymphoma (cHL): Evaluation of Modified Progression-Free Survival (mPFS) and Traditional PFS in the Phase 3 ECHELON-1 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
